<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38239343</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Immunological and virological triggers of type 1 diabetes: insights and implications.</ArticleTitle><Pagination><StartPage>1326711</StartPage><MedlinePgn>1326711</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1326711</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1326711</ELocationID><Abstract><AbstractText>Type 1 diabetes (T1D) is caused by an autoimmune process which culminates in the destruction of insulin-producing beta cells in the pancreas. It is widely believed that a complex and multifactorial interplay between genetic and environmental factors, such as viruses, play a crucial role in the development of the disease. Research over the past few decades has shown that there is not one single viral culprit, nor one single genetic pathway, causing the disease. Rather, viral infections, most notably enteroviruses (EV), appear to accelerate the autoimmune process leading to T1D and are often seen as a precipitator of clinical diagnosis. In support of this hypothesis, the use of anti-viral drugs has recently shown efficacy in preserving beta cell function after onset of diabetes. In this review, we will discuss the various pathways that viral infections utilize to accelerate the development of T1D. There are three key mechanisms linking viral infections to beta-cell death: One is modulated by the direct infection of islets by viruses, resulting in their impaired function, another occurs in a more indirect fashion, by modulating the immune system, and the third is caused by heightened stress on the beta-cell by interferon-mediated increase of insulin resistance. The first two aspects are surprisingly difficult to study, in the case of the former, because there are still many questions about how viruses might persist for longer time periods. In the latter, indirect/immune case, viruses might impact immunity as a hit-and-run scenario, meaning that many or all direct viral footprints quickly vanish, while changes imprinted upon the immune system and the anti-islet autoimmune response persist. Given the fact that viruses are often associated with the precipitation of clinical autoimmunity, there are concerns regarding the impact of the recent global coronavirus-2019 (COVID-19) pandemic on the development of autoimmune disease. The long-term effects of COVID-19 infection on T1D will therefore be discussed, including the increased development of new cases of T1D. Understanding the interplay between viral infections and autoimmunity is crucial for advancing our knowledge in this field and developing targeted therapeutic interventions. In this review we will examine the intricate relationship between viral infections and autoimmunity and discuss potential considerations for prevention and treatment strategies.</AbstractText><CopyrightInformation>Copyright © 2024 Lemos, Hirani and von Herrath.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lemos</LastName><ForeName>Joana R N</ForeName><Initials>JRN</Initials><AffiliationInfo><Affiliation>Diabetes Research Institute (DRI), University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirani</LastName><ForeName>Khemraj</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Diabetes Research Institute (DRI), University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrine, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Herrath</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diabetes Research Institute (DRI), University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrine, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Chief Medical Office, Novo Nordisk A/S, Søborg, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">environmental factors</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword></KeywordList><CoiStatement>Author MH was employed by the company Novo Nordisk A/S. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>3</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38239343</ArticleId><ArticleId IdType="pmc">PMC10794398</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1326711</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Houeiss P, Luce S, Boitard C. Environmental triggering of type 1 diabetes autoimmunity. Front Endocrinol (Lausanne) (2022) 13:933965. doi: 10.3389/fendo.2022.933965</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.933965</ArticleId><ArticleId IdType="pmc">PMC9353023</ArticleId><ArticleId IdType="pubmed">35937815</ArticleId></ArticleIdList></Reference><Reference><Citation>Luckett AM, Weedon MN, Hawkes G, Leslie RD, Oram RA, Grant SFA. Utility of genetic risk scores in type 1 diabetes. Diabetologia (2023) 66(9):1589–600. doi: 10.1007/s00125-023-05955-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-023-05955-y</ArticleId><ArticleId IdType="pmc">PMC10390619</ArticleId><ArticleId IdType="pubmed">37439792</ArticleId></ArticleIdList></Reference><Reference><Citation>Aarnisalo J, Veijola R, Vainionpää R, Simell O, Knip M, Ilonen J. Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes. Diabetologia (2008) 51:769–72. doi: 10.1007/s00125-008-0945-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-008-0945-8</ArticleId><ArticleId IdType="pubmed">18278478</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikarinen S, Tauriainen S, Hober D, Lucas B, Vazeou A, Sioofy-Khojine A, et al. . Virus antibody survey in different European populations indicates risk association between Coxsackievirus B1 and type 1 diabetes. Diabetes (2014) 63:655–62. doi: 10.2337/db13-0620</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-0620</ArticleId><ArticleId IdType="pubmed">24009257</ArticleId></ArticleIdList></Reference><Reference><Citation>Alnek K, Talja I, Laht B, Metsküla K, Mandel M, Reppo I, et al. . Iga-type enterovirus antibodies are increased among adults and children with recently diagnosed type 1 diabetes. BioMed Res Int (2022) 2022:7603062. doi: 10.1155/2022/7603062</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/7603062</ArticleId><ArticleId IdType="pmc">PMC9357813</ArticleId><ArticleId IdType="pubmed">35958821</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampousi AM, Carlsson S, Löfvenborg JE. Dietary factors and risk of islet autoimmunity and type 1 diabetes: A systematic review and meta-analysis. Ebiomedicine (2021) 72:103633. doi: 10.1016/j.ebiom.2021.103633</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103633</ArticleId><ArticleId IdType="pmc">PMC8523874</ArticleId><ArticleId IdType="pubmed">34656932</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender C, Rajendran S, Von Herrath MG. New insights into the role of autoreactive Cd8 T cells and cytokines in human type 1 diabetes. Front Endocrinol (Lausanne) (2020) 11:606434. doi: 10.3389/fendo.2020.606434</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.606434</ArticleId><ArticleId IdType="pmc">PMC7813992</ArticleId><ArticleId IdType="pubmed">33469446</ArticleId></ArticleIdList></Reference><Reference><Citation>Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as A mechanism of autoimmune disease. Clin Rev Allergy Immunol (2012) 42:102–11. doi: 10.1007/s12016-011-8294-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-011-8294-7</ArticleId><ArticleId IdType="pmc">PMC3266166</ArticleId><ArticleId IdType="pubmed">22095454</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim CH, Cho S, Shin YM, Choi JM. Emerging role of bystander T cell activation in autoimmune diseases. Bmb Rep (2022) 55:57–64. doi: 10.5483/BMBRep.2022.55.2.183</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2022.55.2.183</ArticleId><ArticleId IdType="pmc">PMC8891623</ArticleId><ArticleId IdType="pubmed">35000675</ArticleId></ArticleIdList></Reference><Reference><Citation>Apaolaza PS, Balcacean D, Zapardiel-Gonzalo J, Nelson G, Lenchik N, Akhbari P, et al. . Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes. Sci Adv (2021) 7(9):eabd6527. doi: 10.1126/sciadv.abd6527</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd6527</ArticleId><ArticleId IdType="pmc">PMC7904254</ArticleId><ArticleId IdType="pubmed">33627420</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzlau JM, Gu Y, Michels A, Rewers M, Haskins K, Yu L. Identification of autoantibodies to A hybrid insulin peptide in type 1 diabetes. Diagnostics (Basel) (2023) 13(17):2859. doi: 10.3390/diagnostics13172859</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13172859</ArticleId><ArticleId IdType="pmc">PMC10487141</ArticleId><ArticleId IdType="pubmed">37685398</ArticleId></ArticleIdList></Reference><Reference><Citation>Shichkin VP, Antica M. Key factors for thymic function and development. Front Immunol (2022) 13:926516. doi: 10.3389/fimmu.2022.926516</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.926516</ArticleId><ArticleId IdType="pmc">PMC9280625</ArticleId><ArticleId IdType="pubmed">35844535</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Paiva R, Flavell RA. Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective. Immunology (2018) 153:161–70. doi: 10.1111/imm.12867</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12867</ArticleId><ArticleId IdType="pmc">PMC5765377</ArticleId><ArticleId IdType="pubmed">29155454</ArticleId></ArticleIdList></Reference><Reference><Citation>Castañeda J, Hidalgo Y, Sauma D, Rosemblatt M, Bono MR, Núñez S. The multifaceted roles of B cells in the thymus: from immune tolerance to autoimmunity. Front Immunol (2021) 12:766698. doi: 10.3389/fimmu.2021.766698</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.766698</ArticleId><ArticleId IdType="pmc">PMC8591215</ArticleId><ArticleId IdType="pubmed">34790201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Rudra D. Emerging functions of regulatory T cells in tissue homeostasis. Front Immunol (2018) 9:883. doi: 10.3389/fimmu.2018.00883</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00883</ArticleId><ArticleId IdType="pmc">PMC5989423</ArticleId><ArticleId IdType="pubmed">29887862</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihantola EL, Viisanen T, Gazali AM, Näntö-Salonen K, Juutilainen A, Moilanen L, et al. . Effector T cell resistance to suppression and Stat3 signaling during the development of human type 1 diabetes. J Immunol (2018) 201:1144–53. doi: 10.4049/jimmunol.1701199</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1701199</ArticleId><ArticleId IdType="pubmed">30006377</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Calvo T, Christoffersson G, Bender C, Von Herrath MG, Mallone R, Kent SC, et al. . Means, motive, and opportunity: do non-islet-reactive infiltrating T cells contribute to autoimmunity in type 1 diabetes? Front Immunol (2021) 12:683091. doi: 10.3389/fimmu.2021.683091</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.683091</ArticleId><ArticleId IdType="pmc">PMC8242234</ArticleId><ArticleId IdType="pubmed">34220832</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinami RS, Oldstone MB, Wroblewska Z, Frankel ME, Koprowski H. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U.S.A. (1983) 80:2346–50. doi: 10.1073/pnas.80.8.2346</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.80.8.2346</ArticleId><ArticleId IdType="pmc">PMC393817</ArticleId><ArticleId IdType="pubmed">6300911</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DF, Rozek MM, et al. . Molecular mimicry, anti-Coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J Immunol (1995) 154:2983–95. doi: 10.4049/jimmunol.154.6.2983</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.154.6.2983</ArticleId><ArticleId IdType="pubmed">7533190</ArticleId></ArticleIdList></Reference><Reference><Citation>Vreugdenhil GR, Geluk A, Ottenhoff TH, Melchers WJ, Roep BO, Galama JM. Molecular mimicry in diabetes mellitus: the homologous domain in Coxsackie B virus protein 2c and islet autoantigen Gad65 is highly conserved in the Coxsackie B-like enteroviruses and binds to the diabetes associated Hla-Dr3 molecule. Diabetologia (1998) 41:40–6. doi: 10.1007/s001250050864</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001250050864</ArticleId><ArticleId IdType="pubmed">9498628</ArticleId></ArticleIdList></Reference><Reference><Citation>Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell (1995) 80:695–705. doi: 10.1016/0092-8674(95)90348-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90348-8</ArticleId><ArticleId IdType="pmc">PMC7133435</ArticleId><ArticleId IdType="pubmed">7534214</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science (1998) 279:1344–7. doi: 10.1126/science.279.5355.1344</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.279.5355.1344</ArticleId><ArticleId IdType="pubmed">9478893</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppieters KT, Wiberg A, Von Herrath MG. Viral infections and molecular mimicry in type 1 diabetes. Apmis (2012) 120:941–9. doi: 10.1111/apm.12011</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apm.12011</ArticleId><ArticleId IdType="pmc">PMC5774991</ArticleId><ArticleId IdType="pubmed">23051179</ArticleId></ArticleIdList></Reference><Reference><Citation>Christoffersson G, Ratliff SS, Von Herrath MG. Interference with pancreatic sympathetic signaling halts the onset of diabetes in mice. Sci Adv (2020) 6(35):eabb2878. doi: 10.1126/sciadv.abb2878</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abb2878</ArticleId><ArticleId IdType="pmc">PMC7531904</ArticleId><ArticleId IdType="pubmed">33052874</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: A review on the potential interaction and molecular mechanisms. Viruses (2019) 11(8):762. doi: 10.3390/v11080762</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11080762</ArticleId><ArticleId IdType="pmc">PMC6723519</ArticleId><ArticleId IdType="pubmed">31430946</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintana FJ, Patel B, Yeste A, Nyirenda M, Kenison J, Rahbari R, et al. . Epitope spreading as an early pathogenic event in pediatric multiple sclerosis. Neurology (2014) 83:2219–26. doi: 10.1212/WNL.0000000000001066</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001066</ArticleId><ArticleId IdType="pmc">PMC4277672</ArticleId><ArticleId IdType="pubmed">25381299</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller SD, Katz-Levy Y, Neville KL, Vanderlugt CL. Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler's virus infection of the central nervous system. Adv Virus Res (2001) 56:199–217. doi: 10.1016/S0065-3527(01)56008-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(01)56008-X</ArticleId><ArticleId IdType="pubmed">11450300</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuohy VK, Kinkel RP. Epitope spreading: A mechanism for progression of autoimmune disease. Arch Immunol Ther Exp (Warsz) (2000) 48:347–51.</Citation><ArticleIdList><ArticleId IdType="pubmed">11140461</ArticleId></ArticleIdList></Reference><Reference><Citation>von Herrath M, Sanda S, Herold K. Type 1 diabetes as A relapsing-remitting disease? Nat Rev Immunol (2007) 7:988–94. doi: 10.1038/nri2192</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2192</ArticleId><ArticleId IdType="pubmed">17982429</ArticleId></ArticleIdList></Reference><Reference><Citation>Op de Beeck A, Eizirik DL. Viral infections in type 1 diabetes mellitus–why the B cells? Nat Rev Endocrinol (2016) 12:263–73. doi: 10.1038/nrendo.2016.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2016.30</ArticleId><ArticleId IdType="pmc">PMC5348720</ArticleId><ArticleId IdType="pubmed">27020257</ArticleId></ArticleIdList></Reference><Reference><Citation>Faulkner CL, Luo YX, Isaacs S, Rawlinson WD, Craig ME, Kim KW. The virome in early life and childhood and development of islet autoimmunity and type 1 diabetes: A systematic review and meta-analysis of observational studies. Rev Med Virol (2021) 31:1–14. doi: 10.1002/rmv.2209</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2209</ArticleId><ArticleId IdType="pmc">PMC8518965</ArticleId><ArticleId IdType="pubmed">33378601</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua MP, Alidjinou EK, Hober D. Persistent Coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol (2022) 18:503–16. doi: 10.1038/s41574-022-00688-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00688-1</ArticleId><ArticleId IdType="pmc">PMC9157043</ArticleId><ArticleId IdType="pubmed">35650334</ArticleId></ArticleIdList></Reference><Reference><Citation>McGillicuddy FC, Chiquoine EH, Hinkle CC, Kim RJ, Shah R, Roche HM, et al. . Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the Jak/Stat pathway. J Biol Chem (2009) 284:31936–44. doi: 10.1074/jbc.M109.061655</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.061655</ArticleId><ArticleId IdType="pmc">PMC2797265</ArticleId><ArticleId IdType="pubmed">19776010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkin TJ. The convergence of type 1 and type 2 diabetes in childhood: the accelerator hypothesis. Pediatr Diabetes (2012) 13:334–9. doi: 10.1111/j.1399-5448.2011.00831.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-5448.2011.00831.x</ArticleId><ArticleId IdType="pubmed">22059423</ArticleId></ArticleIdList></Reference><Reference><Citation>Subauste A, Gianani R, Chang AM, Plunkett C, Pietropaolo SL, Zhang YJ, et al. . Islet autoimmunity identifies A unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes. PloS One (2014) 9:e106537. doi: 10.1371/journal.pone.0106537</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0106537</ArticleId><ArticleId IdType="pmc">PMC4165581</ArticleId><ArticleId IdType="pubmed">25226365</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks-Worrell BM, Tjaden AH, Edelstein SL, Palomino B, Utzschneider KM, Arslanian S, et al. . Islet autoimmunity in adults with impaired glucose tolerance and recently diagnosed, treatment naïve type 2 diabetes in the restoring insulin secretion (Rise) study. Front Immunol (2021) 12:640251. doi: 10.3389/fimmu.2021.640251</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.640251</ArticleId><ArticleId IdType="pmc">PMC8108986</ArticleId><ArticleId IdType="pubmed">33981301</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W, Jiang N, Ebert PJ, Kidd BA, Müller S, Lund PJ, et al. . Clonal deletion prunes but does not eliminate self-specific Aβ Cd8(+) T lymphocytes. Immunity (2015) 42:929–41. doi: 10.1016/j.immuni.2015.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.05.001</ArticleId><ArticleId IdType="pmc">PMC4455602</ArticleId><ArticleId IdType="pubmed">25992863</ArticleId></ArticleIdList></Reference><Reference><Citation>Luczyński W, Stasiak-Barmuta A, Urban R, Urban M, Florys B, Hryszko M. Lower percentages of T regulatory cells in children with type 1 diabetes - preliminary report. Pediatr Endocrinol Diabetes Metab (2009) 15:34–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19454187</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahran AM, Elsayh KI, Metwalley KA. Regulatory T cells in children with recently diagnosed type 1 diabetes. Indian J Endocrinol Metab (2012) 16:952–7. doi: 10.4103/2230-8210.102998</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2230-8210.102998</ArticleId><ArticleId IdType="pmc">PMC3510966</ArticleId><ArticleId IdType="pubmed">23226641</ArticleId></ArticleIdList></Reference><Reference><Citation>Visperas A, Vignali DA. Are regulatory T cells defective in type 1 diabetes and can we fix them? J Immunol (2016) 197:3762–70. doi: 10.4049/jimmunol.1601118</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601118</ArticleId><ArticleId IdType="pmc">PMC5119643</ArticleId><ArticleId IdType="pubmed">27815439</ArticleId></ArticleIdList></Reference><Reference><Citation>Damian RT. Molecular mimicry: antigen sharing by parasite and host and its consequences. Am Nat (1964) 98:129–49. doi: 1086/282313</Citation></Reference><Reference><Citation>Ellis NM, Li Y, Hildebrand W, Fischetti VA, Cunningham MW. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol (2005) 175:5448–56. doi: 10.4049/jimmunol.175.8.5448</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.8.5448</ArticleId><ArticleId IdType="pubmed">16210652</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedström AK. Risk factors for multiple sclerosis in the context of epstein-barr virus infection. Front Immunol (2023) 14:1212676. doi: 10.3389/fimmu.2023.1212676</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1212676</ArticleId><ArticleId IdType="pmc">PMC10406387</ArticleId><ArticleId IdType="pubmed">37554326</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi-Maharlooei M, Madley R, Borsotti C, Ferreira LMR, Sharp RC, Brehm MA, et al. . Modeling human T1d-associated autoimmune processes. Mol Metab (2022) 56:101417. doi: 10.1016/j.molmet.2021.101417</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2021.101417</ArticleId><ArticleId IdType="pmc">PMC8739876</ArticleId><ArticleId IdType="pubmed">34902607</ArticleId></ArticleIdList></Reference><Reference><Citation>Christen U, Hintermann E, Holdener M, Von Herrath MG. Viral triggers for autoimmunity: is the 'Glass of molecular mimicry' Half full or half empty? J Autoimmun (2010) 34:38–44. doi: 10.1016/j.jaut.2009.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2009.08.001</ArticleId><ArticleId IdType="pmc">PMC2819590</ArticleId><ArticleId IdType="pubmed">19716269</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson AP, Harp CT, Noronha A, Miller SD. The experimental autoimmune encephalomyelitis (Eae) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol (2014) 122:173–89. doi: 10.1016/B978-0-444-52001-2.00008-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-52001-2.00008-X</ArticleId><ArticleId IdType="pmc">PMC3981554</ArticleId><ArticleId IdType="pubmed">24507518</ArticleId></ArticleIdList></Reference><Reference><Citation>Amdare N, Purcell AW, Dilorenzo TP. Noncontiguous T cell epitopes in autoimmune diabetes: from mice to men and back again. J Biol Chem (2021) 297:100827. doi: 10.1016/j.jbc.2021.100827</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100827</ArticleId><ArticleId IdType="pmc">PMC8233151</ArticleId><ArticleId IdType="pubmed">34044020</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinic MM, Juedes AE, Bresson D, Homann D, Skak K, Huber C, et al. . Minimal impact of A de novo-expressed beta-cell autoantigen on spontaneous diabetes development in nod mice. Diabetes (2007) 56:1059–68. doi: 10.2337/db05-0062</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db05-0062</ArticleId><ArticleId IdType="pubmed">17395746</ArticleId></ArticleIdList></Reference><Reference><Citation>Fousteri G, Jasinski J, Dave A, Nakayama M, Pagni P, Lambolez F, et al. . Following the fate of one insulin-reactive Cd4 T cell: conversion into teffs and tregs in the periphery controls diabetes in nod mice. Diabetes (2012) 61:1169–79. doi: 10.2337/db11-0671</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db11-0671</ArticleId><ArticleId IdType="pmc">PMC3331775</ArticleId><ArticleId IdType="pubmed">22403296</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasiewicz K, Pokora-Pachowicz A, Kiciak S. Autoimmune reactions in the course of the hepatitis C virus (HCV) infection. Clin Exp Hepatol (2015) 1:39–43. doi: 10.5114/ceh.2015.51804</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ceh.2015.51804</ArticleId><ArticleId IdType="pmc">PMC5497407</ArticleId><ArticleId IdType="pubmed">28856254</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampino R, Marrone A, Restivo L, Guerrera B, Sellitto A, Rinaldi L, et al. . Chronic HCV infection and inflammation: clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol (2013) 5:528–40. doi: 10.4254/wjh.v5.i10.528</Citation><ArticleIdList><ArticleId IdType="doi">10.4254/wjh.v5.i10.528</ArticleId><ArticleId IdType="pmc">PMC3812455</ArticleId><ArticleId IdType="pubmed">24179612</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Cao ZM, Zhang LL, Dai XC, Liu ZJ, Zeng YX, et al. . Helicobacter pylori and autoimmune diseases: involving multiple systems. Front Immunol (2022) 13:833424. doi: 10.3389/fimmu.2022.833424</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.833424</ArticleId><ArticleId IdType="pmc">PMC8866759</ArticleId><ArticleId IdType="pubmed">35222423</ArticleId></ArticleIdList></Reference><Reference><Citation>Jog NR, James JA. Epstein barr virus and autoimmune responses in systemic lupus erythematosus. Front Immunol (2020) 11:623944. doi: 10.3389/fimmu.2020.623944</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.623944</ArticleId><ArticleId IdType="pmc">PMC7886683</ArticleId><ArticleId IdType="pubmed">33613559</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijay K. Toll-like receptors in immunity and inflammatory diseases: past, present, and future. Int Immunopharmacol (2018) 59:391–412. doi: 10.1016/j.intimp.2018.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC7106078</ArticleId><ArticleId IdType="pubmed">29730580</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabouri S, Benkahla MA, Kiosses WB, Rodriguez-Calvo T, Zapardiel-Gonzalo J, Castillo E, et al. . Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes. J Autoimmun (2020) 107:102378. doi: 10.1016/j.jaut.2019.102378</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102378</ArticleId><ArticleId IdType="pmc">PMC7237334</ArticleId><ArticleId IdType="pubmed">31818546</ArticleId></ArticleIdList></Reference><Reference><Citation>Koivisto VA, Pelkonen R, Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes (1989) 38:641–7. doi: 10.2337/diab.38.5.641</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.38.5.641</ArticleId><ArticleId IdType="pubmed">2653935</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilarrasa N, San Jose P, Rubio M, Lecube A. Obesity in patients with type 1 diabetes: links, risks and management challenges. Diabetes Metab Syndr Obes (2021) 14:2807–27. doi: 10.2147/DMSO.S223618</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DMSO.S223618</ArticleId><ArticleId IdType="pmc">PMC8232956</ArticleId><ArticleId IdType="pubmed">34188505</ArticleId></ArticleIdList></Reference><Reference><Citation>Krischer JP, Lernmark Å., Hagopian WA, Rewers MJ, Mcindoe R, Toppari J, et al. . Sars-Cov-2 - no increased islet autoimmunity or type 1 diabetes in teens. N Engl J Med (2023) 389:474–5. doi: 10.1056/NEJMc2216477</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2216477</ArticleId><ArticleId IdType="pmc">PMC10481371</ArticleId><ArticleId IdType="pubmed">37530831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Nasr M, D'addio F, Montefusco L, Usuelli V, Loretelli C, Rossi A, et al. . Indirect and direct effects of Sars-Cov-2 on human pancreatic islets. Diabetes (2022) 71:1579–90. doi: 10.2337/db21-0926</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db21-0926</ArticleId><ArticleId IdType="pmc">PMC9490452</ArticleId><ArticleId IdType="pubmed">35499468</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Souza D, Empringham J, Pechlivanoglou P, Uleryk EM, Cohen E, Shulman R. Incidence of diabetes in children and adolescents during the Covid-19 pandemic: A systematic review and meta-analysis. JAMA Netw Open (2023) 6:e2321281. doi: 10.1001/jamanetworkopen.2023.21281</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.21281</ArticleId><ArticleId IdType="pmc">PMC10314307</ArticleId><ArticleId IdType="pubmed">37389869</ArticleId></ArticleIdList></Reference><Reference><Citation>Müller JA, Gros R, Conzelmann C, Krüger J, Merle U, Steinhart J, et al. . Sars-Cov-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab (2021) 3:149–65. doi: 10.1038/s42255-021-00347-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00347-1</ArticleId><ArticleId IdType="pubmed">33536639</ArticleId></ArticleIdList></Reference><Reference><Citation>Metwally AA, Mehta P, Johnson BS, Nagarjuna A, Snyder MP. Covid-19-induced new-onset diabetes: trends and technologies. Diabetes (2021) 70:2733–44. doi: 10.2337/dbi21-0029</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dbi21-0029</ArticleId><ArticleId IdType="pmc">PMC8660988</ArticleId><ArticleId IdType="pubmed">34686519</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight JS, Caricchio R, Casanova JL, Combes AJ, Diamond B, Fox SE, et al. . The intersection of Covid-19 and autoimmunity. J Clin Invest (2021) 131(24):e154886. doi: 10.1172/JCI154886</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI154886</ArticleId><ArticleId IdType="pmc">PMC8670833</ArticleId><ArticleId IdType="pubmed">34710063</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sawalha AH, Lu Q. Covid-19 and autoimmune diseases. Curr Opin Rheumatol (2021) 33:155–62. doi: 10.1097/BOR.0000000000000776</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000776</ArticleId><ArticleId IdType="pmc">PMC7880581</ArticleId><ArticleId IdType="pubmed">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Zebardast A, Hasanzadeh A, Ebrahimian Shiadeh SA, Tourani M, Yahyapour Y. COVID-19: A trigger of autoimmune diseases. Cell Biol Int (2023) 47:848–58. doi: 10.1002/cbin.11997</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11997</ArticleId><ArticleId IdType="pubmed">36740221</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcangeletti MC, Caselli E. Recent advances in unveiling the role of beta-herpesviruses in autoimmune diseases. Microorganisms (2021) 47(5):848–58. doi: 10.3390/microorganisms9122572</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9122572</ArticleId><ArticleId IdType="pmc">PMC8705016</ArticleId><ArticleId IdType="pubmed">34946173</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolz MM, Sciallis GF, Pittelkow MR. Human herpesviruses 6, 7, and 8 from A dermatologic perspective. Mayo Clin Proc (2012) 87:1004–14. doi: 10.1016/j.mayocp.2012.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.04.010</ArticleId><ArticleId IdType="pmc">PMC3538396</ArticleId><ArticleId IdType="pubmed">22819486</ArticleId></ArticleIdList></Reference><Reference><Citation>Broccolo F, Fusetti L, Ceccherini-Nelli L. Possible role of human herpesvirus 6 as A trigger of autoimmune disease. Scientificworldjournal (2013) 2013:867389. doi: 10.1155/2013/867389</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/867389</ArticleId><ArticleId IdType="pmc">PMC3825270</ArticleId><ArticleId IdType="pubmed">24282390</ArticleId></ArticleIdList></Reference><Reference><Citation>Agut H, Bonnafous P, Gautheret-Dejean A. Laboratory and clinical aspects of human herpesvirus 6 infections. Clin Microbiol Rev (2015) 28:313–35. doi: 10.1128/CMR.00122-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00122-14</ArticleId><ArticleId IdType="pmc">PMC4402955</ArticleId><ArticleId IdType="pubmed">25762531</ArticleId></ArticleIdList></Reference><Reference><Citation>Roep BO, Thomaidou S, Van Tienhoven R, Zaldumbide A. Type 1 diabetes mellitus as A disease of the B-cell (Do not blame the immune system?). Nat Rev Endocrinol (2021) 17:150–61. doi: 10.1038/s41574-020-00443-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-00443-4</ArticleId><ArticleId IdType="pmc">PMC7722981</ArticleId><ArticleId IdType="pubmed">33293704</ArticleId></ArticleIdList></Reference><Reference><Citation>Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, Vp1, in the islets of patients with recent-onset type 1 diabetes. Diabetologia (2011) 54:2417–20. doi: 10.1007/s00125-011-2192-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-011-2192-7</ArticleId><ArticleId IdType="pubmed">21597997</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L, Genoni A, Puggioni A, Campani D, Richardson SJ, Flaxman CS, et al. . Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the divid study. Diabetologia (2022) 65(12):2108–20. doi: 10.1007/s00125-022-05779-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05779-2</ArticleId><ArticleId IdType="pmc">PMC9630231</ArticleId><ArticleId IdType="pubmed">35953727</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaacs SR, Roy A, Dance B, Ward EJ, Foskett DB, Maxwell AJ, et al. . Enteroviruses and risk of islet autoimmunity or type 1 diabetes: systematic review and meta-analysis of controlled observational studies detecting viral nucleic acids and proteins. Lancet Diabetes Endocrinol (2023) 11(8):578–92. doi: 10.1016/S2213-8587(23)00122-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(23)00122-5</ArticleId><ArticleId IdType="pubmed">37390839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Ye F, Chen Y, Xu J, Zhao Y, Wang Y, et al. . Association between enterovirus infection and type 1 diabetes risk: A meta-analysis of 38 case-control studies. Front Endocrinol (Lausanne) (2021) 12:706964. doi: 10.3389/fendo.2021.706964</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.706964</ArticleId><ArticleId IdType="pmc">PMC8453141</ArticleId><ArticleId IdType="pubmed">34557158</ArticleId></ArticleIdList></Reference><Reference><Citation>Hober D, Sane F. Enteroviral pathogenesis of type 1 diabetes. Discovery Med (2010) 10:151–60.</Citation><ArticleIdList><ArticleId IdType="pubmed">20807476</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn LM, Wong FS, Narendran P. Environmental determinants of type 1 diabetes: from association to proving causality. Front Immunol (2021) 12:737964. doi: 10.3389/fimmu.2021.737964</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.737964</ArticleId><ArticleId IdType="pmc">PMC8518604</ArticleId><ArticleId IdType="pubmed">34659229</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L, Mynarek IM, Ponzi E, Mørk FB, Hessel TW, Roald T, et al. . Pleconaril and Ribavirin in new-onset type 1 diabetes: A phase 2 randomized trial. Nat Med (2023) 29(11):2902–8. doi: 10.1038/s41591-023-02576-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02576-1</ArticleId><ArticleId IdType="pmc">PMC10667091</ArticleId><ArticleId IdType="pubmed">37789144</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Calvo T. Enterovirus infection and type 1 diabetes: unraveling the crime scene. Clin Exp Immunol (2019) 195:15–24. doi: 10.1111/cei.13223</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13223</ArticleId><ArticleId IdType="pmc">PMC6300647</ArticleId><ArticleId IdType="pubmed">30307605</ArticleId></ArticleIdList></Reference><Reference><Citation>Petzold A, Solimena M, Knoch KP. Mechanisms of beta cell dysfunction associated with viral infection. Curr Diabetes Rep (2015) 15:73. doi: 10.1007/s11892-015-0654-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-015-0654-x</ArticleId><ArticleId IdType="pmc">PMC4539350</ArticleId><ArticleId IdType="pubmed">26280364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodik M, Skog O, Lukinius A, Isaza-Correa JM, Kuipers J, Giepmans BN, et al. . Enterovirus infection of human islets of langerhans affects B-cell function resulting in disintegrated islets, decreased glucose stimulated insulin secretion and loss of golgi structure. BMJ Open Diabetes Res Care (2016) 4:e000179. doi: 10.1136/bmjdrc-2015-000179</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2015-000179</ArticleId><ArticleId IdType="pmc">PMC4985798</ArticleId><ArticleId IdType="pubmed">27547409</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyalwidhe JO, Gallagher GR, Glenn LM, Morris MA, Vangala P, Jurczyk A, et al. . Coxsackievirus-induced proteomic alterations in primary human islets provide insights for the etiology of diabetes. J Endocr Soc (2017) 1:1272–86. doi: 10.1210/js.2017-00278</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/js.2017-00278</ArticleId><ArticleId IdType="pmc">PMC5686651</ArticleId><ArticleId IdType="pubmed">29264452</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertin A, Sane F, Gmyr V, Lobert D, Dechaumes A, Kerr-Conte J, et al. . Coxsackievirus-B4 infection of human primary pancreatic ductal cell cultures results in impairment of differentiation into insulin-producing cells. Viruses (2019) 11(7):597. doi: 10.3390/v11070597</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11070597</ArticleId><ArticleId IdType="pmc">PMC6669621</ArticleId><ArticleId IdType="pubmed">31269669</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua MP, Bertin A, Sane F, Gimeno JP, Fournier I, Salzet M, et al. . Persistence of Coxsackievirus B4 in pancreatic B cells disturbs insulin maturation, pattern of cellular proteins, and Dna methylation. Microorganisms (2021) 9(6):1125. doi: 10.3390/microorganisms9061125</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9061125</ArticleId><ArticleId IdType="pmc">PMC8224704</ArticleId><ArticleId IdType="pubmed">34067388</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui T, Kobayashi T, Jimbo E, Aida K, Shimada A, Oikawa Y, et al. . Bi-glandular and persistent enterovirus infection and distinct changes of the pancreas in slowly progressive type 1 diabetes mellitus. Sci Rep (2023) 13:6977. doi: 10.1038/s41598-023-33011-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-33011-7</ArticleId><ArticleId IdType="pmc">PMC10147722</ArticleId><ArticleId IdType="pubmed">37117225</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecchio F, Carré A, Korenkov D, Zhou Z, Apaolaza P, Tuomela S, et al. . Coxsackievirus infection induces direct pancreatic B-cell killing but poor anti-viral Cd8+ T-cell responses. Biorxiv (2023) 21:2023.08.19.553954. doi: 10.1101/2023.08.19.553954</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.08.19.553954</ArticleId><ArticleId IdType="pmc">PMC10917340</ArticleId><ArticleId IdType="pubmed">38446892</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford SE, Ramani S, Tate JE, Parashar UD, Svensson L, Hagbom M, et al. . Rotavirus infection. Nat Rev Dis Primers (2017) 3:17083. doi: 10.1038/nrdp.2017.83</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.83</ArticleId><ArticleId IdType="pmc">PMC5858916</ArticleId><ArticleId IdType="pubmed">29119972</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan H, Nasirudeen NA, Ruzlan MAF, Mohd Jamil MA, Ismail NAS, Wahab AA, et al. . Acute infectious gastroenteritis: the causative agents, omics-based detection of antigens and novel biomarkers. Children (Basel) (2021) 8(12):1112. doi: 10.3390/children8121112</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children8121112</ArticleId><ArticleId IdType="pmc">PMC8700514</ArticleId><ArticleId IdType="pubmed">34943308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramig RF. Pathogenesis of intestinal and systemic rotavirus infection. J Virol (2004) 78:10213–20. doi: 10.1128/JVI.78.19.10213-10220.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.19.10213-10220.2004</ArticleId><ArticleId IdType="pmc">PMC516399</ArticleId><ArticleId IdType="pubmed">15367586</ArticleId></ArticleIdList></Reference><Reference><Citation>Dian Z, Sun Y, Zhang G, Xu Y, Fan X, Yang X, et al. . Rotavirus-related systemic diseases: clinical manifestation, evidence and pathogenesis. Crit Rev Microbiol (2021) 47:580–95. doi: 10.1080/1040841X.2021.1907738</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1040841X.2021.1907738</ArticleId><ArticleId IdType="pubmed">33822674</ArticleId></ArticleIdList></Reference><Reference><Citation>Honeyman MC, Stone NL, Falk BA, Nepom G, Harrison LC. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol (2010) 184:2204–10. doi: 10.4049/jimmunol.0900709</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0900709</ArticleId><ArticleId IdType="pubmed">20083660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen R, Mahlab-Guri K, Atali M, Elbirt D. Viruses and celiac disease: what do we know? Clin Exp Med (2023) 23(7):2931–9. doi: 10.1007/s10238-023-01070-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-023-01070-9</ArticleId><ArticleId IdType="pmc">PMC10134706</ArticleId><ArticleId IdType="pubmed">37103650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar T, Das S, Nandy P, Bhowmick R, Nandy A. In silico study of potential autoimmune threats from rotavirus infection. Comput Biol Chem (2014) 51:51–6. doi: 10.1016/j.compbiolchem.2014.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiolchem.2014.05.003</ArticleId><ArticleId IdType="pubmed">24929545</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahari S, Chatterjee D, Negi S, Kaur J, Singh B, Agrewala JN. Morbid sequences suggest molecular mimicry between microbial peptides and self-antigens: A possibility of inciting autoimmunity. Front Microbiol (2017) 8:1938. doi: 10.3389/fmicb.2017.01938</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.01938</ArticleId><ArticleId IdType="pmc">PMC5640720</ArticleId><ArticleId IdType="pubmed">29062305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler AG. The countdown to type 1 diabetes: when, how and why does the clock start? Diabetologia (2023) 66:1169–78. doi: 10.1007/s00125-023-05927-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-023-05927-2</ArticleId><ArticleId IdType="pmc">PMC10212739</ArticleId><ArticleId IdType="pubmed">37231274</ArticleId></ArticleIdList></Reference><Reference><Citation>Holloway G, Fleming FE, Coulson BS. Mhc class I expression in intestinal cells is reduced by rotavirus infection and increased in bystander cells lacking rotavirus antigen. Sci Rep (2018) 8:67. doi: 10.1038/s41598-017-18464-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18464-x</ArticleId><ArticleId IdType="pmc">PMC5758578</ArticleId><ArticleId IdType="pubmed">29311575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Mumtaz M, Maxwell AJ, Isaacs SR, Laiho JE, Rawlinson WD, et al. . Respiratory infections and type 1 diabetes: potential roles in pathogenesis. Rev Med Virol (2023) 33:E2429. doi: 10.1002/rmv.2429</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2429</ArticleId><ArticleId IdType="pmc">PMC10909571</ArticleId><ArticleId IdType="pubmed">36790804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascherio A, Munger KL. Ebv and autoimmunity. Curr Top Microbiol Immunol (2015) 390:365–85. doi: 10.1007/978-3-319-22822-8_15</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-22822-8_15</ArticleId><ArticleId IdType="pubmed">26424654</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldan SS, Lieberman PM. Epstein-barr virus and multiple sclerosis. Nat Rev Microbiol (2023) 21:51–64. doi: 10.1038/s41579-022-00770-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00770-5</ArticleId><ArticleId IdType="pmc">PMC9362539</ArticleId><ArticleId IdType="pubmed">35931816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lönnrot M, Lynch KF, Rewers M, Lernmark Å., Vehik K, Akolkar B, et al. . Gastrointestinal infections modulate the risk for insulin autoantibodies as the first-appearing autoantibody in the teddy study. Diabetes Care (2023) 46(11):1908–15. doi: 10.2337/figshare.23823507.v1</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/figshare.23823507.v1</ArticleId><ArticleId IdType="pmc">PMC10620548</ArticleId><ArticleId IdType="pubmed">37607456</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach JF, Chatenoud L. The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetes. Cold Spring Harb Perspect Med (2012) 2:a007799. doi: 10.1101/cshperspect.a007799</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a007799</ArticleId><ArticleId IdType="pmc">PMC3281594</ArticleId><ArticleId IdType="pubmed">22355800</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdaca G, Greco M, Borro M, Gangemi S. Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms. Autoimmun Rev (2021) 20:102845. doi: 10.1016/j.autrev.2021.102845</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102845</ArticleId><ArticleId IdType="pubmed">33971339</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi CM, von Herrath MG. Viral trigger for type 1 diabetes: pros and cons. Diabetes (2008) 57:2863–71. doi: 10.2337/db07-1023</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db07-1023</ArticleId><ArticleId IdType="pmc">PMC2570378</ArticleId><ArticleId IdType="pubmed">18971433</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie Z, Aboulnasr F, Natesampillai S, Burke SP, Krogman A, Bren GD, et al. . Both HIV-infected and uninfected cells express trailshort, which confers trail resistance upon bystander cells within the microenvironment. J Immunol (2018) 200:1110–23. doi: 10.4049/jimmunol.1701113</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1701113</ArticleId><ArticleId IdType="pmc">PMC5808399</ArticleId><ArticleId IdType="pubmed">29263214</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi CM, Estes EA, Oldham JE, von Herrath MG. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J Clin Invest (2009) 119:1515–23. doi: 10.1172/JCI38503</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI38503</ArticleId><ArticleId IdType="pmc">PMC2689128</ArticleId><ArticleId IdType="pubmed">19478458</ArticleId></ArticleIdList></Reference><Reference><Citation>Warshauer JT, Bluestone JA, Anderson MS. New frontiers in the treatment of type 1 diabetes. Cell Metab (2020) 31:46–61. doi: 10.1016/j.cmet.2019.11.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2019.11.017</ArticleId><ArticleId IdType="pmc">PMC6986815</ArticleId><ArticleId IdType="pubmed">31839487</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluestone JA, Buckner JH, Herold KC. Immunotherapy: building A bridge to A cure for type 1 diabetes. Science (2021) 373:510–6. doi: 10.1126/science.abh1654</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abh1654</ArticleId><ArticleId IdType="pubmed">34326232</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Coz C, Oldridge DA, Herati RS, De Luna N, Garifallou J, Cruz Cabrera E, et al. . Human T follicular helper clones seed the germinal center-resident regulatory pool. Sci Immunol (2023) 8:eade8162. doi: 10.1126/sciimmunol.ade8162</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.ade8162</ArticleId><ArticleId IdType="pmc">PMC10329285</ArticleId><ArticleId IdType="pubmed">37027481</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold KC, Bundy BN, Long SA, Bluestone JA, Dimeglio LA, Dufort MJ, et al. . An anti-cd3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med (2019) 381:603–13. doi: 10.1056/NEJMoa1902226</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1902226</ArticleId><ArticleId IdType="pmc">PMC6776880</ArticleId><ArticleId IdType="pubmed">31180194</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua MP, Mercier A, Alhazmi A, Sane F, Alidjinou EK, Hober D. Fighting enteroviral infections to prevent type 1 diabetes. Microorganisms (2022) 10(4):768. doi: 10.3390/microorganisms10040768</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10040768</ArticleId><ArticleId IdType="pmc">PMC9031364</ArticleId><ArticleId IdType="pubmed">35456818</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr ALJ, Evans-Molina C, Oram RA. Precision medicine in type 1 diabetes. Diabetologia (2022) 65:1854–66. doi: 10.1007/s00125-022-05778-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05778-3</ArticleId><ArticleId IdType="pmc">PMC9522741</ArticleId><ArticleId IdType="pubmed">35994083</ArticleId></ArticleIdList></Reference><Reference><Citation>Smura T, Natri O, Ylipaasto P, Hellman M, Al-Hello H, Piemonti L, et al. . Enterovirus strain and type-specific differences in growth kinetics and virus-induced cell destruction in human pancreatic duct epithelial hpde cells. Virus Res (2015) 210:188–97. doi: 10.1016/j.virusres.2015.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.08.003</ArticleId><ArticleId IdType="pubmed">26260332</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettigole SE, Glimcher LH. Endoplasmic reticulum stress in immunity. Annu Rev Immunol (2015) 33:107–38. doi: 10.1146/annurev-immunol-032414-112116</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-032414-112116</ArticleId><ArticleId IdType="pubmed">25493331</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes SA, Papa FR. The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol (2015) 10:173–94. doi: 10.1146/annurev-pathol-012513-104649</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-012513-104649</ArticleId><ArticleId IdType="pmc">PMC5568783</ArticleId><ArticleId IdType="pubmed">25387057</ArticleId></ArticleIdList></Reference><Reference><Citation>Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes (2005) 54 Suppl 2:S97–107. doi: 10.2337/diabetes.54.suppl_2.s97</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.54.suppl_2.s97</ArticleId><ArticleId IdType="pubmed">16306347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci (2019) 20(23):6008. doi: 10.3390/ijms20236008</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20236008</ArticleId><ArticleId IdType="pmc">PMC6929211</ArticleId><ArticleId IdType="pubmed">31795299</ArticleId></ArticleIdList></Reference><Reference><Citation>Roep BO, Peakman M. Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb Perspect Med (2012) 2:a007781. doi: 10.1101/cshperspect.a007781</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a007781</ArticleId><ArticleId IdType="pmc">PMC3312399</ArticleId><ArticleId IdType="pubmed">22474615</ArticleId></ArticleIdList></Reference><Reference><Citation>Panzer JK, Hiller H, Cohrs CM, Almaça J, Enos SJ, Beery M, et al. . Pancreas tissue slices from organ donors enable in situ analysis of type 1 diabetes pathogenesis. JCI Insight (2020) 5(8):e134525. doi: 10.1172/jci.insight.134525</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.134525</ArticleId><ArticleId IdType="pmc">PMC7205437</ArticleId><ArticleId IdType="pubmed">32324170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Zaghouani H. Antigen-specific therapy against type 1 diabetes: mechanisms and perspectives. Immunotherapy (2014) 6:155–64. doi: 10.2217/imt.13.172</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/imt.13.172</ArticleId><ArticleId IdType="pubmed">24491089</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudini A, Fierabracci A. Advances in immunotherapeutic approaches to type 1 diabetes. Int J Mol Sci (2023) 24(11):9220. doi: 10.3390/ijms24119220</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24119220</ArticleId><ArticleId IdType="pmc">PMC10253167</ArticleId><ArticleId IdType="pubmed">37298175</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunne JL, Richardson SJ, Atkinson MA, Craig ME, Dahl-Jørgensen K, Flodström-Tullberg M, et al. . Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes. Diabetologia (2019) 62:744–53. doi: 10.1007/s00125-019-4811-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-019-4811-7</ArticleId><ArticleId IdType="pmc">PMC6450860</ArticleId><ArticleId IdType="pubmed">30675626</ArticleId></ArticleIdList></Reference><Reference><Citation>Niklasson B, Klitz W, Juntti-Berggren L, Berggren PO, Lindquist L. Effectiveness of antivirals in A type 1 diabetes model and the move toward human trials. Viral Immunol (2020) 33:594–9. doi: 10.1089/vim.2020.0039</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2020.0039</ArticleId><ArticleId IdType="pubmed">32758075</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold KC, Gitelman SE, Ehlers MR, Gottlieb PA, Greenbaum CJ, Hagopian W, et al. . Teplizumab (Anti-cd3 mab) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in A randomized controlled trial: metabolic and immunologic features at baseline identify A subgroup of responders. Diabetes (2013) 62:3766–74. doi: 10.2337/db13-0345</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-0345</ArticleId><ArticleId IdType="pmc">PMC3806618</ArticleId><ArticleId IdType="pubmed">23835333</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazmi A, Nekoua MP, Mercier A, Vergez I, Sane F, Alidjinou EK, et al. . Combating Coxsackievirus B infections. Rev Med Virol (2023) 33:E2406. doi: 10.1002/rmv.2406</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2406</ArticleId><ArticleId IdType="pubmed">36371612</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>